Abstract:Background We recently reported that miR-1 was one of the most significantly downregulated microRNAs in gastric cancer (GC) patients from The Cancer Genome Atlas microRNA sequencing data. Here we aim to elucidate the role of miR-1 in gastric carcinogenesis. Methods We measured miR-1 expression in human GC cell lines and 90 paired primary GC samples, and analyzed the association of its status with clinicopathological features. The effect of miR-1 on GC cells was evaluated by proliferation and migration assay. To identify the target genes of miR-1, bioinformatic analysis and protein array analysis were performed. Moreover, the regulation mechanism of miR-1 with regard to these predicted targets was investigated by quantitative PCR (qPCR), Western blot, ELISA, and endothelial cell tube formation. The putative binding site of miR-1 on target genes was assessed by a reporter assay. Results Expression of miR-1 was obviously decreased in GC cell lines and primary tissues. Patients with low miR-1 expression had significantly shorter overall survival compared with those with high miR-1 expression ( P = 0.0027). Overexpression of miR-1 in GC cells inhibited proliferation, migration, and tube formation of endothelial cells by suppressing expression of vascular endothelial growth factor A (VEGF-A) and endothelin 1 (EDN1). Conversely, inhibition of miR-1 with use of antago-miR-1 caused an increase in expression of VEGF-A and EDN1 in nonmalignant GC cells or low-malignancy GC cells. Conclusions MiR-1 acts as a tumor suppressor by inhibiting angiogenesis-related growth factors in human gastric cancer. Downregulated miR-1 not only promotes cellular proliferation and migration of GC cells, but may activates proangiogenesis signaling and stimulates the proliferation and migration of endothelial cells, indicating the possibility of new strategies for GC therapy.

Tumor Suppressor Mir-1 Inhibits Tumor Growth and Metastasis by Simultaneously Targeting Multiple Genes

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

Upregulation of Microrna‑1 Inhibits Proliferation and Metastasis of Breast Cancer

Mir‑1 Inhibits the Progression of Colon Cancer by Regulating the Expression of Vascular Endothelial Growth Factor

MicroRNA-1 Acts As a Tumor Suppressor Microrna by Inhibiting Angiogenesis-Related Growth Factors in Human Gastric Cancer

Mir-145, Mir-133a and Mir-133b Inhibit Proliferation, Migration, Invasion and Cell Cycle Progression Via Targeting Transcription Factor Sp1 in Gastric Cancer

Tumor-Suppressive Mir-663 Gene Induces Mitotic Catastrophe Growth Arrest In Human Gastric Cancer Cells

Mir-107 Regulates Tumor Progression by Targeting NF1 in Gastric Cancer

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

Mir-873-5p Controls Gastric Cancer Progression by Targeting Hedgehog-Gli Signaling

Mir-202 Acts As a Potential Tumor Suppressor in Breast Cancer

Mir-194 Suppresses Metastasis of Non-Small Cell Lung Cancer Through Regulating Expression of BMP1 and P27(kip1).

Mir-19b Promotes Tumor Growth and Metastasis Via Targeting Tp53

Tumor-promoting Properties of Mir-8084 in Breast Cancer Through Enhancing Proliferation, Suppressing Apoptosis and Inducing Epithelial–mesenchymal Transition

Mir-1 Suppresses the Growth of Esophageal Squamous Cell Carcinoma in Vivo and in Vitro Through the Downregulation of MET, Cyclin D1 and CDK4 Expression.

Transforming Growth Factor-Β1 Promotes Breast Cancer Metastasis by Downregulating Mir-196A-3p Expression.

MiR-10b-5p inhibits tumorigenesis in gastric cancer xenograft mice model through down-regulating Tiam1

Mir-152 As a Tumor Suppressor Microrna: Target Recognition and Regulation in Cancer.

Tumor Suppressor Mir-449A Inhibits the Development of Gastric Cancer Via Down-Regulation of SGPL1.

Mir-340 and ZEB1 Negative Feedback Loop Regulates TGF-β- Mediated Breast Cancer Progression.